Jamie Cavanagh

The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML

R. Hills, N. Russell, A. Burnett, 2012, British journal of haematology.

Thalidomide therapy for low-risk Myelodysplasia.

G. Mufti, S. Killick, D. Bowen, 2005, Leukemia research.

Bortezomib is effective in primary plasma cell leukemia

W. Wachsman, C. Matthews, P. Kettle, 2006, Leukemia & lymphoma.

Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy

G. Morgan, B. Sirohi, R. Powles, 2007, Hematology.